Argentina vs Spain: HIV/AIDS deaths averted by antiretroviral therapy
Argentina
4,021 deaths
in 2024
Spain
3,213 deaths
in 2024
Argentina rank
46th
Spain rank
48th
HIV/AIDS deaths averted by antiretroviral therapy over time
- Argentina
- Spain
How they compare
Argentina currently reports 4,021 deaths against 3,213 deaths in Spain, a difference of 808 deaths.
That makes Argentina's figure about 1.3 times Spain's.
The two have swapped places 1 time across 35 shared years of data; in 1990 it was Spain ahead.
Argentina ranks 46th and Spain ranks 48th of 157 countries.
Across the 4 decades both report, Argentina averaged higher in 1 and Spain in 3.
Head to head by decade
| Decade | Argentina | Spain | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 149.65 deaths | 1,429 deaths | 1,279 deaths | Spain |
| 2000s | 2,595 deaths | 5,789 deaths | 3,194 deaths | Spain |
| 2010s | 3,781 deaths | 4,277 deaths | 496.48 deaths | Spain |
| 2020s | 4,018 deaths | 3,345 deaths | 673.17 deaths | Argentina |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Argentina or Spain?
- Argentina, at 4,021 deaths against 3,213 deaths in Spain as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Argentina and Spain?
- 808 deaths, with Argentina ahead.
- How many years of comparable data are there for Argentina and Spain?
- 35 years are reported by both, from 1990 to 2024.
- How do Argentina and Spain rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Argentina ranks 46th and Spain ranks 48th of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.